Director Williams Lewis T sold Protagonist Therapeutics ($PTGX) shares once on the open market in the last year, for a total of $1.5 million. His most recent sale occurred on February 17, 2026. These sales rank 4,080th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | M | Stock Option (right to buy) | 18000 | $0.00 | 6,000.0000 | 63,573,048 | 0.00% | 0.03% |
| Feb. 17, 2026 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | M | Common Stock | 18000 | $10.84 | 25,825.0000 | 63,573,048 | 230.03% | 0.03% |
| Feb. 17, 2026 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | S | Common Stock | 18000 | $82.42 | 7,825.0000 | 63,573,048 | 69.70% | 0.03% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | A | Stock Option (right to buy) | 3762 | $0.00 | 3,762.0000 | 63,573,048 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | A | Common Stock | 2695 | $0.00 | 7,825.0000 | 63,573,048 | 52.53% | 0.00% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | A | Common Stock | 5130 | $0.00 | 5,130.0000 | 65,077,722 | 9999.99% | 0.01% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | A | Stock Option (right to buy) | 6584 | $0.00 | 6,584.0000 | 65,077,722 | 9999.99% | 0.01% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | Williams Lewis T | Director | A | Stock Option (right to buy) | 25700 | $0.00 | 25,700.0000 | 56,763,559 | 9999.99% | 0.05% |